Abstract

Safety and feasibility of hematopoietic progenitor stem cell collection by mobilization with plerixafor followed by apheresis vs bone marrow harvest in patients with sickle cell disease in the multi-center HGB-206 trial.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Results from the Completed Hgb-205 Trial of Lentiglobin for β-Thalassemia and Lentiglobin for Sickle Cell Disease Gene Therapy
... Nicolas Hebert
Blood | VOL. 134
, et. al. ... Nicolas Hebert
13 Nov 2019
Successful Plerixafor-Mediated Mobilization, Apheresis, and Lentiviral Vector Transduction of Hematopoietic Stem Cells in Patients with Severe Sickle Cell Disease
Mohammed Asmal ... Janet L Kwiatkowski
Blood | VOL. 130
Mohammed Asmal, et. al.Mohammed Asmal ... Janet L Kwiatkowski
07 Dec 2017
Current Results of Lentiglobin Gene Therapy in Patients with Severe Sickle Cell Disease Treated Under a Refined Protocol in the Phase 1 Hgb-206 Study
Mohammed Asmal ... Weiliang Shi
Blood | VOL. 132
Mohammed Asmal, et. al.Mohammed Asmal ... Weiliang Shi
29 Nov 2018
The role of chemokine activation of Rac GTPases in hematopoietic stem cell marrow homing, retention, and peripheral mobilization
Michael Jansen ... Jose A Cancelas
Experimental Hematology | VOL. 34
Michael Jansen, et. al.Michael Jansen ... Jose A Cancelas
22 Jul 2006
View more papers

More From: American journal of hematology

Paper Title
Journal
Date
Author
A randomized double-blind pilot study to evaluate the efficacy, safety, and tolerability of intravenous iron versus oral iron for the treatment of restless legs syndrome in patients with iron deficiency anemia.
Richard Allen ... Huzefa Bahrain
American journal of hematology | VOL. 99
Richard Allen, et. al.Richard Allen ... Huzefa Bahrain
01 Jun 2024
-
-
American Journal of Hematology | VOL. 99
--
01 Jun 2024
Toxicities associated with tyrosine kinase inhibitor maintenance following allogeneic hematopoietic cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tamer Othman ... Matthew Mei
American journal of hematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Matthew Mei
28 May 2024
Outcomes following allogeneic hematopoietic cell transplantation relapse in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Tamer Othman ... Paul Koller
American journal of hematology | VOL. -
Tamer Othman, et. al.Tamer Othman ... Paul Koller
27 May 2024
View more papers